Literature DB >> 17378994

Nonpharmacologic measures and drug compliance in patients with heart failure: data from the EuroHeart Failure Survey.

Mitja Lainscak1, John G F Cleland, Mattie J Lenzen, Irena Keber, Kevin Goode, Ferenc Follath, Michel Komajda, Karl Swedberg.   

Abstract

Advice on lifestyle, diet, vaccination, and therapy are part of the standard management of heart failure (HF). However, there is little information on whether patients with HF recall receiving such recommendations and, if so, whether they report following them. We obtained information on the recall of and adherence to nonpharmacologic advice from patients enrolled in the EuroHeart Failure Survey. This article focuses on 2,331 patients who had a clinical diagnosis of HF during the index admission and attended an interview 12 weeks after discharge. Their mean age was 67 +/- 12 years and 38% were women. Patients recalled receiving 4.1 +/- 2.7 items of advice with higher rates in Central Europe and the Mediterranean region. Recall of dietary advice (cholesterol or fat intake, 63%; dietary salt, 60%) was higher than for some other interventions (influenza vaccination, 36%; avoidance of nonsteroidal anti-inflammatory drugs, 17%). Among those who recalled the advice, a substantial proportion indicated that they did not follow advice completely (cholesterol and fat intake, 61%; dietary salt, 63%; influenza vaccination, 75%; avoidance of nonsteroidal anti-inflammatory drugs, 80%), although few patients indicated they ignored the advice completely. Patients who recalled >4 items versus < or =4 items of advice were younger and more often received angiotensin-converting enzyme inhibitors (71% vs 62%), beta-blockers (51% vs 38%), and spironolactone (25% vs 21%). In conclusion, after hospitalization for HF, many patients do not recall nonpharmacologic advice. In addition, a substantial proportion of those who recall the advice follow it incompletely. Younger age and prescription of appropriate pharmacologic treatment are associated with higher rates of recall and implementation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17378994     DOI: 10.1016/j.amjcard.2006.12.018

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Beta blockers and glucose metabolism in chronic heart failure: friend or foe?

Authors:  W Doehner; S D Anker
Journal:  Clin Res Cardiol       Date:  2008-01       Impact factor: 5.460

Review 2.  Self care in patients with chronic heart failure.

Authors:  Barbara Riegel; Christopher S Lee; Victoria Vaughan Dickson
Journal:  Nat Rev Cardiol       Date:  2011-07-19       Impact factor: 32.419

3.  A Positive Psychology Intervention to Promote Health Behaviors in Heart Failure: A Proof-of-Concept Trial.

Authors:  Christopher M Celano; Melanie E Freedman; Eleanor E Beale; Federico Gomez-Bernal; Jeff C Huffman
Journal:  J Nerv Ment Dis       Date:  2018-10       Impact factor: 2.254

4.  Self-care confidence mediates the relationship between perceived social support and self-care maintenance in adults with heart failure.

Authors:  Crystal W Cené; Laura Beth Haymore; Diane Dolan-Soto; Feng-Chang Lin; Michael Pignone; Darren A Dewalt; Jia-Rong Wu; Christine Delong Jones; Giselle Corbie-Smith
Journal:  J Card Fail       Date:  2013-03       Impact factor: 5.712

Review 5.  The influence of heart failure self-care on health outcomes: hypothetical cardioprotective mechanisms.

Authors:  Christopher S Lee; Nancy C Tkacs; Barbara Riegel
Journal:  J Cardiovasc Nurs       Date:  2009 May-Jun       Impact factor: 2.083

6.  Economic evaluation of warfarin, dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillation.

Authors:  Torbjørn Wisløff; Gunhild Hagen; Marianne Klemp
Journal:  Pharmacoeconomics       Date:  2014-06       Impact factor: 4.981

7.  General public awareness of heart failure: results of questionnaire survey during Heart Failure Awareness Day 2011.

Authors:  Mitja Lainscak; Mitja Letonja; Dragan Kovacic; Lea Majc Hodoscek; Apolon Marolt; Cvetka Melihen Bartolic; Marija Mulej; Meta Penko; Janez Poles; Tinkara Ravnikar; Mojca Savnik Iskra; Cirila Slemenik Pusnik; Borut Jug
Journal:  Arch Med Sci       Date:  2014-05-13       Impact factor: 3.318

8.  Effect of the Optimize Heart Failure Care Program on clinical and patient outcomes - The pilot implementation in Vietnam.

Authors:  Thi Nam Phuong Do; Quang Huan Do; Martin R Cowie; Ngoc Ban Ha; Van Dung Do; Thi Hao Do; Thi Thuy Hang Nguyen; Thuy Loan Tran; Thi Ngoc Oanh Nguyen; Thi My Hanh Nguyen; Thi To Quyen Chau; Thi Tuyen Tien Nguyen; Chi Thanh Nguyen; Kieu Diem Trang Tran; Thi Nha Diem Nguyen; Ngoc Yen Tuyet Nguyen; Kim Tuyen Le; Thanh Thu Phan; Thi Lan Vo; Thuy Dung Huynh; Thi Mai Hoa Pham; Thi Anh Thu Nguyen; Xuan Nguyen Nguyen; Thi Ngoc Thuy Tran; Thi Ngoc Quyen Truong; Bao Thanh Bui; Thanh Quang Bui; Quoc Thanh Ha; Cam Thuy Truc La; Phat Tai Le; Huu Duc Nguyen; Thuc Linh Nguyen; Ngoc Manh Tran
Journal:  Int J Cardiol Heart Vasc       Date:  2019-03-07

9.  Management of heart failure with reduced ejection fraction in Europe: design of the ARIADNE registry.

Authors:  Uwe Zeymer; Andrew L Clark; Vivencio Barrios; Thibaud Damy; Jaroslaw Drożdż; Candida Fonseca; Lars H Lund; Gabriele Di Comite; Stephan Hupfer; Aldo P Maggioni
Journal:  ESC Heart Fail       Date:  2020-02-06

10.  Structured chronic primary care and health-related quality of life in chronic heart failure.

Authors:  Marije Bosch; Trudy van der Weijden; Richard Grol; Henk Schers; Reinier Akkermans; Louis Niessen; Michel Wensing
Journal:  BMC Health Serv Res       Date:  2009-06-19       Impact factor: 2.655

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.